Elizabeth Rita Volkmann

Title(s)HS Associate Clinical Professor, Medicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease
    NIH K23HL150237Apr 1, 2020 - Mar 31, 2025
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):137-152. Raghu G, Montesi SB, Silver RM, Hossain T, Macrea M, Herman D, Barnes H, Adegunsoye A, Azuma A, Chung L, Gardner GC, Highland KB, Hudson M, Kaner RJ, Kolb M, Scholand MB, Steen V, Thomson CC, Volkmann ER, Wigley FM, Burlile D, Kemper KA, Knight SL, Ghazipura M. PMID: 37772985; PMCID: PMC10806429.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    2. Summary for Clinicians: Clinical Practice Guideline for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. Ann Am Thorac Soc. 2024 Jan; 21(1):12-16. Hossain T, Montesi SB, Volkmann ER, Thomson CC, Ruminjo JK, Silver RM, Ghazipura M, Raghu G. PMID: 37856309.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Outcomes of systemic sclerosis associated interstitial lung disease patients with a persistent inflammatory phenotype based on serial CRP measurements. Thorax. 2023 Dec; 78(12):1166-1167. Volkmann ER, Tashkin DP. PMID: 37798113.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization. Rheumatology (Oxford). 2023 10 03; 62(10):3433-3438. Luebker S, Frech TM, Assassi S, Skaug B, Gordon JK, Lakin K, Bernstein EJ, Luo Y, Steen VD, Shah AA, Hummers LK, Richardson C, Moore DF, Khanna D, Castelino FV, Chung L, Kapoor P, Hant FN, Shanmugam VK, VanBuren JM, Alvey J, Harding M, Shah A, Makol A, Lebiedz-Odrobina D, Thomas JK, Volkmann ER, Molitor JA, Sandorfi N. PMID: 37079727; PMCID: PMC10547507.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study. Arthritis Res Ther. 2023 09 04; 25(1):162. Hamberg V, Sohrabian A, Volkmann ER, Wildt M, Löfdahl A, Wuttge DM, Hesselstrand R, Dellgren G, Westergren-Thorsson G, Rönnelid J, Andréasson K. PMID: 37667402; PMCID: PMC10476305.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy. ACR Open Rheumatol. 2023 Oct; 5(10):547-555. Volkmann ER, Wilhalme H, Assassi S, Kim GHJ, Goldin J, Kuwana M, Tashkin DP, Roth MD. PMID: 37592449; PMCID: PMC10570669.
      View in: PubMed   Mentions: 2  
    7. Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial. Arthritis Care Res (Hoboken). 2023 12; 75(12):2501-2507. Volkmann ER, McMahan ZH, Smith V, Jouneau S, Miede C, Alves M, Herrick AL, SENSCIS Trial Investigators. PMID: 37357024.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Combining rituximab with mycophenolate for the treatment of interstitial lung disease. Eur Respir J. 2023 06; 61(6). Volkmann ER. PMID: 37290812; PMCID: PMC10516316.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Living with Systemic Sclerosis: A Patient and Physician Perspective. Rheumatol Ther. 2023 Aug; 10(4):785-792. Young A, Rudy B, Volkmann ER. PMID: 37173569; PMCID: PMC10326232.
      View in: PubMed   Mentions:
    10. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford). 2023 05 02; 62(5):1877-1886. Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT, Dellaripa PF, Conway R, Rosas I, Bhatt N, Hsu V, Ingegnoli F, Kahaleh B, Garcha P, Gupta N, Khanna S, Korsten P, Lin C, Mathai SC, Strand V, Doyle TJ, Steen V, Zoz DF, Ovalles-Bonilla J, Rodriguez-Pinto I, Shenoy PD, Lewandoski A, Belloli E, Lescoat A, Nagaraja V, Ye W, Huang S, Maher T, Khanna D. PMID: 36173318; PMCID: PMC10152284.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome. Semin Arthritis Rheum. 2023 06; 60:152185. Nguyen AD, Andréasson K, McMahan ZH, Bukiri H, Howlett N, Lagishetty V, Lee SM, Jacobs JP, Volkmann ER. PMID: 36870237; PMCID: PMC10148899.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Associations Between Patterns of Esophageal Dysmotility and Extra-Intestinal Features in Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023 08; 75(8):1715-1724. Tucker AE, Perin J, Volkmann ER, Abdi T, Shah AA, Pandolfino J, Silver RM, McMahan ZH. PMID: 36576023.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Association of Symptoms of Gastroesophageal Reflux, Esophageal Dilation, and Progression of Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Care Res (Hoboken). 2023 08; 75(8):1690-1697. Volkmann ER, Tashkin DP, Leng M, Kim GHJ, Goldin J, Roth MD. PMID: 36504432; PMCID: PMC10258217.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences. Lancet Rheumatol. 2023 03; 5(3):e116-e118. Volkmann ER, Sparks JA, Hoffmann-Vold AM, Doyle TJ, Emery P, Dieudé P. PMID: 38251607; PMCID: PMC10495035.
      View in: PubMed   Mentions: 2  Translation:Humans
    15. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. RMD Open. 2023 02; 9(1). Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton CP. PMID: 36796874; PMCID: PMC9936273.
      View in: PubMed   Mentions: 1  Translation:Humans
    16. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir Res. 2023 Jan 09; 24(1):6. Rahaghi FF, Hsu VM, Kaner RJ, Mayes MD, Rosas IO, Saggar R, Steen VD, Strek ME, Bernstein EJ, Bhatt N, Castelino FV, Chung L, Domsic RT, Flaherty KR, Gupta N, Kahaleh B, Martinez FJ, Morrow LE, Moua T, Patel N, Shlobin OA, Southern BD, Volkmann ER, Khanna D. PMID: 36624431.
      View in: PubMed   Mentions: 14     Fields:    
    17. Is there a role for the microbiome in systemic sclerosis? Expert Rev Clin Immunol. 2023 03; 19(3):237-240. Volkmann ER. PMID: 36576305; PMCID: PMC9957839.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Micronutrient Deficiencies in Systemic Sclerosis: A Scoping Review. Open Access Rheumatol. 2022; 14:309-327. Nguyen AD, McMahan ZH, Volkmann ER. PMID: 36571105; PMCID: PMC9769137.
      View in: PubMed   Mentions: 1  
    19. Systemic sclerosis. Lancet. 2023 01 28; 401(10373):304-318. Volkmann ER, Andréasson K, Smith V. PMID: 36442487; PMCID: PMC9892343.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    20. Blood Neutrophil Count and Neutrophil-to-Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis Cohorts. Arthritis Care Res (Hoboken). 2023 03; 75(3):648-656. Wareing N, Mohan V, Taherian R, Volkmann ER, Lyons MA, Wilhalme H, Roth MD, Estrada-Y-Martin RM, Skaug B, Mayes MD, Tashkin DP, Assassi S. PMID: 35287250; PMCID: PMC9470772.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    21. Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial. Rheumatology (Oxford). 2022 11 02; 61(11):4397-4408. Volkmann ER, Kreuter M, Hoffmann-Vold AM, Wijsenbeek M, Smith V, Khanna D, Denton CP, Wuyts WA, Miede C, Alves M, Sambevski S, Allanore Y. PMID: 35150246; PMCID: PMC9629379.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    22. World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease. Front Pharmacol. 2022; 13:979788. Saketkoo LA, Escorpizo R, Varga J, Keen KJ, Fligelstone K, Birring SS, Alexanderson H, Pettersson H, Chaudhry HA, Poole JL, Regardt M, LeSage D, Sarver C, Lanario J, Renzoni E, Scholand MB, Lammi MR, Kowal-Bielecka O, Distler O, Frech T, Shapiro L, Varju C, Volkmann ER, Bernstein EJ, Drent M, Obi ON, Patterson KC, Russell AM, Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). PMID: 36313333; PMCID: PMC9615472.
      View in: PubMed   Mentions: 2  
    23. Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials. Lancet Rheumatol. 2022 Oct; 4(10):e679-e687. Hoffmann-Vold AM, Volkmann ER, Allanore Y, Assassi S, de Vries-Bouwstra JK, Smith V, Tschoepe I, Loaiza L, Kanakapura M, Distler O. PMID: 38265966.
      View in: PubMed   Mentions: 1  Translation:Humans
    24. Impact of Sex and Gender on Autoimmune Lung Disease: Opportunities for Future Research: NHLBI Working Group Report. Am J Respir Crit Care Med. 2022 10 01; 206(7):817-823. Volkmann ER, Siegfried J, Lahm T, Ventetuolo CE, Mathai SC, Steen V, Herzog EL, Shansky R, Anguera MC, Danoff SK, Giles JT, Lee YC, Drake W, Maier LA, Lachowicz-Scroggins M, Park H, Banerjee K, Fessel J, Reineck L, Vuga L, Crouser E, Feghali-Bostwick C. PMID: 35549658; PMCID: PMC9799264.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials. Lancet Rheumatol. 2022 Oct; 4(10):e668-e678. Volkmann ER, Tashkin DP, Silver R, Bostwick CF, Assassi S, Frost DB, Leng M, Wilhalme H, Kim GH, Goldin J, Roth MD. PMID: 37745675; PMCID: PMC10518185.
      View in: PubMed   Mentions: 4  
    26. Predicting the Progression of Very Early Systemic Sclerosis: Current Insights. Open Access Rheumatol. 2022; 14:171-186. Bellocchi C, Chung A, Volkmann ER. PMID: 36133926; PMCID: PMC9484572.
      View in: PubMed   Mentions: 3  
    27. Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype. Arthritis Care Res (Hoboken). 2023 02; 75(2):289-298. Cheah JX, Perin J, Volkmann ER, Hummers LK, Pasricha PJ, Wigley FM, McMahan ZH. PMID: 34369086; PMCID: PMC8825888.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment. Curr Opin Rheumatol. 2022 11 01; 34(6):328-336. Volkmann ER, McMahan Z. PMID: 35993874; PMCID: PMC9547962.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    29. Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study. Medicine (Baltimore). 2022 Aug 12; 101(32):e29993. Assassi S, Shao N, Yin Z, Volkmann ER, Zoz DF, Leonard TB. PMID: 35960051; PMCID: PMC9371507.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects. Respir Res. 2022 Jul 05; 23(1):178. Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler JHW, Alves M, Stock C, Distler O. PMID: 35790961; PMCID: PMC9258095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Current advances in the treatment of systemic sclerosis. Curr Opin Pharmacol. 2022 06; 64:102211. Bukiri H, Volkmann ER. PMID: 35447517; PMCID: PMC9466985.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    32. Occupational Exposures and Systemic Sclerosis-Related Lung Disease. Chest. 2022 04; 161(4):874-875. Volkmann ER. PMID: 35396043.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    33. Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease. Ann Rheum Dis. 2022 06; 81(6):854-860. Assassi S, Volkmann ER, Zheng WJ, Wang X, Wilhalme H, Lyons MA, Roth MD, Tashkin DP. PMID: 35190386; PMCID: PMC9117450.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts. ACR Open Rheumatol. 2022 May; 4(5):417-425. Andréasson K, Lee SM, Lagishetty V, Wu M, Howlett N, English J, Hesselstrand R, Clements PJ, Jacobs JP, Volkmann ER. PMID: 35174673; PMCID: PMC9096523.
      View in: PubMed   Mentions: 8  
    35. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score. Arthritis Rheumatol. 2022 03; 74(3):518-526. Kuwana M, Allanore Y, Denton CP, Distler JHW, Steen V, Khanna D, Matucci-Cerinic M, Mayes MD, Volkmann ER, Miede C, Gahlemann M, Quaresma M, Alves M, Distler O. PMID: 34514739; PMCID: PMC9306495.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    36. Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2022 03; 74(3):442-450. McMahan ZH, Tucker AE, Perin J, Volkmann ER, Kulkarni S, Ziessman HA, Pasricha PJ, Wigley FM. PMID: 33064934; PMCID: PMC8050123.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    37. Allogeneic mesenchymal stromal cell transplantation for systemic sclerosis. Lancet Rheumatol. 2022 Feb; 4(2):e74-e75. Volkmann ER, Chai-Ho W. PMID: 38288739; PMCID: PMC10954215.
      View in: PubMed   Mentions:
    38. Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality. Chest. 2022 05; 161(5):1310-1319. Volkmann ER, Tashkin DP, Roth MD, Goldin J, Kim GHJ. PMID: 34896093; PMCID: PMC9131045.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    39. A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc. Best Pract Res Clin Rheumatol. 2021 09; 35(3):101707. Saketkoo LA, Frech T, Varjú C, Domsic R, Farrell J, Gordon JK, Mihai C, Sandorfi N, Shapiro L, Poole J, Volkmann ER, Lammi M, McAnally K, Alexanderson H, Pettersson H, Hant F, Kuwana M, Shah AA, Smith V, Hsu V, Kowal-Bielecka O, Assassi S, Cutolo M, Kayser C, Shanmugam VK, Vonk MC, Fligelstone K, Baldwin N, Connolly K, Ronnow A, Toth B, Suave M, Farrington S, Bernstein EJ, Crofford LJ, Czirják L, Jensen K, Hinchclif M, Hudson M, Lammi MR, Mansour J, Morgan ND, Mendoza F, Nikpour M, Pauling J, Riemekasten G, Russell AM, Scholand MB, Seigart E, Rodriguez-Reyna TS, Hummers L, Walker U, Steen V. PMID: 34538573; PMCID: PMC8670736.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    40. Multiple Manifestations of Systemic Sclerosis Affect Walk Distance. Am J Respir Crit Care Med. 2021 08 01; 204(3):359. Andréasson K, Bengtsson MF, Boström C, Hesselstrand R, Volkmann ER. PMID: 34107236; PMCID: PMC8513583.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best Pract Res Clin Rheumatol. 2021 09; 35(3):101695. Pettersson H, Alexanderson H, Poole JL, Varga J, Regardt M, Russell AM, Salam Y, Jensen K, Mansour J, Frech T, Feghali-Bostwick C, Varjú C, Baldwin N, Heenan M, Fligelstone K, Holmner M, Lammi MR, Scholand MB, Shapiro L, Volkmann ER, Saketkoo LA. PMID: 34217607; PMCID: PMC8478716.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    42. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial. BMJ Open. 2021 06 24; 11(6):e048541. Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø. PMID: 34168032; PMCID: PMC8231046.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    43. Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2021 06; 73(6):1005-1013. Assassi S, Li N, Volkmann ER, Mayes MD, Rünger D, Ying J, Roth MD, Hinchcliff M, Khanna D, Frech T, Clements PJ, Furst DE, Goldin J, Bernstein EJ, Castelino FV, Domsic RT, Gordon JK, Hant FN, Shah AA, Shanmugam VK, Steen VD, Elashoff RM, Tashkin DP. PMID: 33350170; PMCID: PMC8169525.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    44. Natural variability in the disease course of SSc-ILD: implications for treatment. Eur Respir Rev. 2021 Mar 31; 30(159). Vonk MC, Walker UA, Volkmann ER, Kreuter M, Johnson SR, Allanore Y. PMID: 33762426; PMCID: PMC9489046.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    45. Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2021 04; 73(4):671-676. Maher TM, Mayes MD, Kreuter M, Volkmann ER, Aringer M, Castellvi I, Cutolo M, Stock C, Schoof N, Alves M, Raghu G, SENSCIS Trial Investigators. PMID: 33142016; PMCID: PMC8048624.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    46. Molecular imaging for systemic sclerosis-interstitial lung disease. Lancet Rheumatol. 2021 Mar; 3(3):e163-e164. Volkmann ER. PMID: 34337438; PMCID: PMC8323663.
      View in: PubMed   Mentions:
    47. Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis. Eur Med J (Chelmsf). 2020 Dec 10; 7:110-118. Volkmann ER, Hoffmann-Vold AM, Chang YL, Lagishetty V, Clements PJ, Midtvedt Ø, Molberg Ø, Braun J, Jacobs JP. PMID: 36711108; PMCID: PMC9881192.
      View in: PubMed   Mentions: 2  
    48. Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II. ACR Open Rheumatol. 2021 Jan; 3(1):8-16. Volkmann ER, Steen V, Li N, Roth MD, Clements PJ, Furst DE, Assassi S, Khanna D, Kim GJ, Goldin J, Elashoff RM, Tashkin DP. PMID: 33277978; PMCID: PMC7811695.
      View in: PubMed   Mentions: 6  
    49. An ode to the primal tonic of dance-congratulating the Life of Breath project. Lancet Respir Med. 2020 12; 8(12):e90-e91. Saketkoo LA, Alexanderson H, Lammi MR, LeSage D, Jensen K, Scholand MB, Volkmann ER, Russell AM. PMID: 33271133; PMCID: PMC8211031.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. The Association of Autoimmune Disease With Lung Cancer Survival. JAMA Netw Open. 2020 12 01; 3(12):e2030506. Volkmann ER. PMID: 33315108; PMCID: PMC7939078.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. COVID-19 in Patients With Connective Tissue Disease-related Interstitial Lung Disease. J Rheumatol. 2021 03; 48(3):468-470. Truong L, Pourzand L, Volkmann ER. PMID: 32934125; PMCID: PMC7956905.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Tapering glucocorticoids in rheumatoid arthritis. Lancet. 2020 07 25; 396(10246):218-219. Volkmann ER. PMID: 32711782; PMCID: PMC7950817.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis. Expert Opin Pharmacother. 2020 Nov; 21(16):2041-2056. McMahan ZH, Volkmann ER. PMID: 32674612; PMCID: PMC7913471.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis. Semin Arthritis Rheum. 2020 10; 50(5):963-967. Volkmann ER, Tashkin DP, Roth MD, Li N, Charles J, Mayes M, Kim G, Goldin J, Pourzand L, Clements PJ, Furst DE, Khanna D, Elashoff RM, Assassi S. PMID: 32906032; PMCID: PMC7584725.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Update on Morbidity and Mortality in Systemic Sclerosis-Related Interstitial Lung Disease. J Scleroderma Relat Disord. 2021 Feb; 6(1):11-20. Volkmann ER, Fischer A. PMID: 33693057; PMCID: PMC7943067.
      View in: PubMed   Mentions: 24  
    56. Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II. ACR Open Rheumatol. 2020 Jun; 2(6):362-370. Volkmann ER, Tashkin DP, LeClair H, Roth MD, Kim G, Goldin J, Clements PJ, Furst DE, Khanna D. PMID: 32432411; PMCID: PMC7301868.
      View in: PubMed   Mentions: 18  
    57. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020 05; 55(5). Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM. PMID: 32079645; PMCID: PMC7236865.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    58. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2020 02; 72(2):316-325. Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG. PMID: 31430058; PMCID: PMC6994370.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches. J Scleroderma Relat Disord. 2021 Feb; 6(1):37-43. Hoffmann-Vold AM, Volkmann ER. PMID: 35382247; PMCID: PMC8922632.
      View in: PubMed   Mentions: 8  
    60. Gastrointestinal tract microbiota modifications in systemic sclerosis. Eur J Rheumatol. 2020 Oct; 7(Suppl 3):S228-S236. Volkmann ER, Hoffmann-Vold AM. PMID: 31922474; PMCID: PMC7647687.
      View in: PubMed   Mentions: 10  
    61. Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention. Open Access Rheumatol. 2019; 11:283-307. Fischer A, Patel NM, Volkmann ER. PMID: 31849543; PMCID: PMC6910104.
      View in: PubMed   Mentions: 14  
    62. Natural History of Systemic Sclerosis-Related Interstitial Lung Disease: How to Identify a Progressive Fibrosing Phenotype. J Scleroderma Relat Disord. 2020 Mar; 5(2 Suppl):31-40. Volkmann ER. PMID: 33693056; PMCID: PMC7943063.
      View in: PubMed   Mentions: 16  
    63. Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease. EBioMedicine. 2019 Dec; 50:379-386. Hoffmann-Vold AM, Weigt SS, Saggar R, Palchevskiy V, Volkmann ER, Liang LL, Ross D, Ardehali A, Lynch JP, Belperio JA. PMID: 31732480; PMCID: PMC6921223.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    64. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067. Volkmann ER, Tashkin DP, Kuwana M, Li N, Roth MD, Charles J, Hant FN, Bogatkevich GS, Akter T, Kim G, Goldin J, Khanna D, Clements PJ, Furst DE, Elashoff RM, Silver RM, Assassi S. PMID: 31233287; PMCID: PMC6883123.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    65. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease. Expert Rev Clin Immunol. 2019 10; 15(10):1009-1017. Distler O, Volkmann ER, Hoffmann-Vold AM, Maher TM. PMID: 31566449.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    66. Emerging targets of disease-modifying therapy for systemic sclerosis. Nat Rev Rheumatol. 2019 04; 15(4):208-224. Volkmann ER, Varga J. PMID: 30796362.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    67. Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II. J Rheumatol. 2019 10; 46(10):1316-1325. Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM. PMID: 30770517; PMCID: PMC6697251.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    68. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. QJM. 2019 02 01; 112(2):81-93. Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. PMID: 30605544.
      View in: PubMed   Mentions: 2     Fields:    
    69. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). Arthritis Res Ther. 2019 01 16; 21(1):23. Khanna D, Clements PJ, Volkmann ER, Wilhalme H, Tseng CH, Furst DE, Roth MD, Distler O, Tashkin DP. PMID: 30651141; PMCID: PMC6335851.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    70. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195. Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. PMID: 30604506.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    71. Determining progression of scleroderma-related interstitial lung disease. J Scleroderma Relat Disord. 2019 Feb; 4(1):62-70. Volkmann ER, Tashkin DP, Sim M, Kim GH, Goldin J, Clements PJ. PMID: 35382149; PMCID: PMC8922575.
      View in: PubMed   Mentions: 7  
    72. Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis. PLoS One. 2018; 13(11):e0206545. Hoffmann-Vold AM, Weigt SS, Palchevskiy V, Volkmann E, Saggar R, Li N, Midtvedt Ø, Lund MB, Garen T, Fishbein MC, Ardehali A, Ross DJ, Ueland T, Aukrust P, Lynch JP, Elashoff RM, Molberg Ø, Belperio JA. PMID: 30457999; PMCID: PMC6245508.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    73. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis. 2019 01; 78(1):122-130. Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM, SLS I and SLS II study groups. PMID: 30409830; PMCID: PMC6311344.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    74. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II. Ann Am Thorac Soc. 2018 11; 15(11):1286-1295. Goldin JG, Kim GHJ, Tseng CH, Volkmann E, Furst D, Clements P, Brown M, Roth M, Khanna D, Tashkin DP. PMID: 30265153; PMCID: PMC6322015.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    75. Update on the Gastrointestinal Microbiome in Systemic Sclerosis. Curr Rheumatol Rep. 2018 06 25; 20(8):49. Bellocchi C, Volkmann ER. PMID: 29943234.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    76. Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials. Arthritis Care Res (Hoboken). 2018 03; 70(3):439-444. Namas R, Tashkin DP, Furst DE, Wilhalme H, Tseng CH, Roth MD, Kafaja S, Volkmann E, Clements PJ, Khanna D, Participants in the Scleroderma Lung Study I and members of the Scleroderma Lung Study II Research G. PMID: 28544580; PMCID: PMC5700860.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    77. Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). Am J Respir Crit Care Med. 2018 03 01; 197(5):644-652. Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D. PMID: 29099620; PMCID: PMC6008871.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    78. Intestinal microbiome in scleroderma: recent progress. Curr Opin Rheumatol. 2017 Nov; 29(6):553-560. Volkmann ER. PMID: 28719392.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    79. Pulmonary Hypertension Complicating Connective Tissue Disease. Semin Respir Crit Care Med. 2017 10; 38(5):619-635. Volkmann ER, Chung A, Saggar R, Belperio JA, Lynch JP. PMID: 29032565.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II. Arthritis Rheumatol. 2017 07; 69(7):1451-1460. Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM. PMID: 28376288; PMCID: PMC5560126.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    81. Initial Experience of a Primary Urgent Care Clinic Curriculum and Subspecialty Lectureship Series Implementation in a Los Angeles County Hospital. South Med J. 2017 05; 110(5):325-329. Agrawal H, Martinez A, Volkmann ER, Melamed O, Wali S. PMID: 28464172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. BMJ Open Gastroenterol. 2017; 4(1):e000134. Volkmann ER, Hoffmann-Vold AM, Chang YL, Jacobs JP, Tillisch K, Mayer EA, Clements PJ, Hov JR, Kummen M, Midtvedt Ø, Lagishetty V, Chang L, Labus JS, Molberg Ø, Braun J. PMID: 28761687; PMCID: PMC5508636.
      View in: PubMed   Mentions: 43     Fields:    
    83. Silent Survivors. Ann Fam Med. 2017 01; 15(1):77-79. Volkmann ER. PMID: 28376465; PMCID: PMC5217848.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease. Arthritis Res Ther. 2016 12 30; 18(1):305. Volkmann ER, Tashkin DP, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S. PMID: 28038680; PMCID: PMC5203703.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    85. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820. Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. PMID: 28012804; PMCID: PMC5472514.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    86. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies. Ann Am Thorac Soc. 2016 11; 13(11):2045-2056. Volkmann ER, Tashkin DP. PMID: 27560196; PMCID: PMC5122482.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    87. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM, Sclerodema Lung Study II Investigators. PMID: 27469583; PMCID: PMC5014629.
      View in: PubMed   Mentions: 355     Fields:    Translation:Humans
    88. Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome? Cureus. 2016 Jun 30; 8(6):e663. Saif MW, Agarwal A, Hellinger J, Park DJ, Volkmann E. PMID: 27493845; PMCID: PMC4968779.
      View in: PubMed   Mentions: 3  
    89. Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience. Ann Am Thorac Soc. 2016 06; 13(6):793-802. Miele CH, Schwab K, Saggar R, Duffy E, Elashoff D, Tseng CH, Weigt S, Charan D, Abtin F, Johannes J, Derhovanessian A, Conklin J, Ghassemi K, Khanna D, Siddiqui O, Ardehali A, Hunter C, Kwon M, Biniwale R, Lo M, Volkmann E, Torres Barba D, Belperio JA, Sayah D, Mahrer T, Furst DE, Kafaja S, Clements P, Shino M, Gregson A, Kubak B, Lynch JP, Ross D, Saggar R. PMID: 27078625; PMCID: PMC5461989.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    90. Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium. Arthritis Rheumatol. 2016 06; 68(6):1483-92. Volkmann ER, Chang YL, Barroso N, Furst DE, Clements PJ, Gorn AH, Roth BE, Conklin JL, Getzug T, Borneman J, McGovern DP, Tong M, Jacobs JP, Braun J. PMID: 26749064; PMCID: PMC5561666.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    91. Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease. Rheumatology (Sunnyvale). 2015 Jun; 5(2). Volkmann ER, Tashkin DP, Li N, Furst DE, Clements PJ, Elashoff RM. PMID: 28856069; PMCID: PMC5573239.
      View in: PubMed   Mentions: 8  
    92. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches. Rheum Dis Clin North Am. 2015 Aug; 41(3):399-417. Volkmann ER, Furst DE. PMID: 26210126.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    93. Reducing gender disparities in post-total knee arthroplasty expectations through a decision aid. BMC Musculoskelet Disord. 2015 Feb 07; 16:16. Volkmann ER, FitzGerald JD. PMID: 25886129; PMCID: PMC4328497.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    94. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis. 2016 Feb; 75(2):374-81. Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R. PMID: 25452309.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    95. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease. Arthritis Rheumatol. 2014 Jul; 66(7):1900-8. Volkmann ER, Saggar R, Khanna D, Torres B, Flora A, Yoder L, Clements PJ, Elashoff RM, Ross DJ, Agrawal H, Borazan N, Furst DE, Saggar R. PMID: 24729406.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    96. We still don't know how to taper glucocorticoids in rheumatoid arthritis, and we can do better. J Rheumatol. 2013 Oct; 40(10):1646-9. Volkmann ER, Rezai S, Tarp S, Woodworth TG, Furst DE. PMID: 24085754.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    97. Satisfaction and access to clinical care in a rheumatology clinic at a large urban medical center. J Clin Rheumatol. 2012 Jun; 18(4):209-11. Agrawal H, Hay MC, Volkmann ER, Maranian P, Khanna D, Furst DE. PMID: 22647867.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 May; 64(5):625-39. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG. PMID: 22473917; PMCID: PMC4081542.
      View in: PubMed   Mentions: 592     Fields:    Translation:Humans
    99. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation? South Med J. 2012 Feb; 105(2):100-4. Volkmann ER, Taylor M, Ben-Artzi A. PMID: 22267099.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    100. Aberrant right subclavian artery aneurysm. Intern Med J. 2011 Aug; 41(8):641-2. Agrawal H, Volkmann ER. PMID: 21831121.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010 Nov; 62(11):1515-26. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG. PMID: 20662044.
      View in: PubMed   Mentions: 223     Fields:    Translation:Humans
    102. Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):258-65. Volkmann ER, Grossman JM, Sahakian LJ, Skaggs BJ, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH, McMahon M. PMID: 20191526; PMCID: PMC2853476.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    103. Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum. 2009 Aug; 60(8):2428-37. McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N, Charles-Schoeman C, Watson K, Wong WK, Volkmann E, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH. PMID: 19644959; PMCID: PMC2753974.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    104. Determinants of participation in HIV clinical trials: the importance of patients' trust in their provider. HIV Clin Trials. 2009 Mar-Apr; 10(2):104-9. Volkmann ER, Claiborne D, Currier JS. PMID: 19487180.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    Elizabeth's Networks
    Concepts (231)
    Derived automatically from this person's publications.
    Co-Authors (46)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department